NCT04739293View on ClinicalTrials.gov

Study of ON 123300 in Patients With Advanced Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 13, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Solid Tumors, Adult
Interventions
DRUG

ON123300

ON 123300 hard gelatin capsules

Trial Locations (3)

29605

RECRUITING

Greenville Health System, Institute for Oncology Clinical Research, Greenville

49546

RECRUITING

START Midwest, Grand Rapids

75230

RECRUITING

Mary Crowley Cancer Research, Dallas

All Listed Sponsors
lead

Traws Pharma, Inc.

INDUSTRY

NCT04739293 - Study of ON 123300 in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter